The rise of Viagra initially fueled a period of growth for pharma, nevertheless recent changes present a murky scenario for investors. Generic competitors are eroding revenue, and continued patent challenges add https://murrayssge545957.ltfblog.com/39645814/sildenafil-and-pharma-a-precarious-bet